![COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/11/front_matter-JCC-Journal-pdf.jpg)
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease
![ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/04/news-ecco-1080x675.jpg)
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
![PDF) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications PDF) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications](https://i1.rgstatic.net/publication/339011349_ECCO-ESGAR_guideline_for_diagnostic_assessment_in_IBD_part_1_initial_diagnosis_monitoring_of_known_IBD_detection_of_complications/links/5f8990c792851c14bccc3896/largepreview.png)
PDF) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications
![ECCO 2022 Insights: Treatment developments for irritable bowel disease (IBD) and rheumatology - European Medical Journal ECCO 2022 Insights: Treatment developments for irritable bowel disease (IBD) and rheumatology - European Medical Journal](https://fast.wistia.net/embed/medias/kf6v06ruja/thumbnail-320.webp)